Correlation Between SPASX Dividend and 4Dmedical

Can any of the company-specific risk be diversified away by investing in both SPASX Dividend and 4Dmedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SPASX Dividend and 4Dmedical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between SPASX Dividend Opportunities and 4Dmedical, you can compare the effects of market volatilities on SPASX Dividend and 4Dmedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SPASX Dividend with a short position of 4Dmedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of SPASX Dividend and 4Dmedical.

Diversification Opportunities for SPASX Dividend and 4Dmedical

0.11

Correlation Coefficient

SPASX Dividend  4Dmedical

Average diversification

The 3 months correlation between SPASX and 4Dmedical is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding SPASX Dividend Opportunities and 4Dmedical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 4Dmedical and SPASX Dividend is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SPASX Dividend Opportunities are associated (or correlated) with 4Dmedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 4Dmedical has no effect on the direction of SPASX Dividend i.e., SPASX Dividend and 4Dmedical go up and down completely randomly.

Pair Corralation between SPASX Dividend and 4Dmedical

Assuming the 90 days trading horizon SPASX Dividend Opportunities is expected to generate 0.16 times more return on investment than 4Dmedical. However, SPASX Dividend Opportunities is 6.44 times less risky than 4Dmedical. It trades about 0.01 of its potential returns per unit of risk. 4Dmedical is currently generating about -0.01 per unit of risk. If you would invest  162,630  in SPASX Dividend Opportunities on October 2, 2024 and sell it today you would earn a total of  3,240  from holding SPASX Dividend Opportunities or generate 1.99% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

SPASX Dividend Opportunities  vs.  4Dmedical

Pair Trading with SPASX Dividend and 4Dmedical

The main advantage of trading using opposite SPASX Dividend and 4Dmedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SPASX Dividend position performs unexpectedly, 4Dmedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 4Dmedical will offset losses from the drop in 4Dmedical's long position.

The idea behind SPASX Dividend Opportunities and 4Dmedical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.